FDA Says No To Expansion Of Xarelto Use-For The Third Time
The U.S. Food and Drug Administration (FDA) has rejected three attempts by Johnson & Johnson to expand the approval of its anti-blood clotting drug, Xarelto, according to a report in the Wall Street Journal. Xarelto is approved as a preventative medicine for patients with pulmonary…